People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Biotechnology, Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CryOSA, Inc. | — | Biotechnology | Series A | $7.0M | $19.5M | 2018 |
| Entvantage Diagnostics, Inc. | — | Medical Devices | Seed | $6.3M | $15.3M | 2016 |
| Allotrope Medical Inc. | — | Medical Devices | Series A | $5.0M | $93.6M | 2021 |
Donald Gonzales at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Donald Gonzales on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Eadie | 1 | 6 |
| Richard J. Hawkins | 1 | 4 |
| Donald J Gonzales | 1 | 2 |
| Joseph S. Skraba | 1 | 2 |
| David Franklin | 1 | 2 |
| Richard Hawkins | 1 | 2 |
| David Belitz | 1 | 2 |
| Doug French | 1 | 2 |
| Mira Sahney | 1 | 2 |
| Laura Stoltenberg | 1 | 1 |
| John S Paulos | 1 | 1 |
| Russell S Bradley | 1 | 1 |
| Albert Huang | 1 | 1 |
| Blobel S Friedhelm | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.